Beurs gesloten -
Nasdaq
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1,11
USD
|
-2,63%
|
|
-3,48%
|
-16,54%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Marktkapitalisatie
1 |
15,52
|
262,9
|
260,4
|
77,91
|
40,67
|
34,7
|
Bedrijfswaarde
1 |
15,52
|
262,9
|
260,4
|
77,91
|
40,67
|
34,7
|
K/w-verhouding
|
-2,49
x
|
6,12
x
|
7,26
x
|
-5,6
x
|
-1,11
x
|
-1,12
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
72,2
x
|
3,53
x
|
2,66
x
|
2,28
x
|
5,97
x
|
5,96
x
|
Bedrijfswaarde/omzet
|
72,2
x
|
3,53
x
|
2,66
x
|
2,28
x
|
5,97
x
|
5,96
x
|
Bedrijfswaarde/EBITDA
|
-
|
6.284.706
x
|
4.998.919
x
|
-25.156.840
x
|
-
|
-
|
Bedrijfswaarde/FCF
|
-
|
-
|
6.443.620
x
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
17.340
|
28.269
|
29.160
|
30.918
|
30.581
|
31.260
|
Referentieprijs
2 |
0,8952
|
9,300
|
8,930
|
2,520
|
1,330
|
1,110
|
Datum van publicatie
|
30/03/20
|
25/03/21
|
24/03/22
|
16/03/23
|
14/03/24
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Omzet
1 |
0,215
|
74,55
|
97,89
|
34,22
|
6,812
|
5,825
|
EBITDA
|
-
|
41,83
|
52,09
|
-3,097
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-5,894
|
41,69
|
46,06
|
-26,98
|
-42,71
|
-41,98
|
Operationele Marge
|
-2.741,66%
|
55,93%
|
47,06%
|
-78,85%
|
-626,92%
|
-720,6%
|
Resultaat voor belastingen (EBT)
1 |
-6,196
|
42,57
|
45,64
|
-18,85
|
-38,11
|
-41,54
|
Nettowinst (verlies)
1 |
-6,196
|
42,48
|
36,66
|
-14,24
|
-35,33
|
-31,15
|
Nettomarge
|
-2.882,06%
|
56,98%
|
37,45%
|
-41,61%
|
-518,68%
|
-534,78%
|
WPA
2 |
-0,3600
|
1,520
|
1,230
|
-0,4500
|
-1,200
|
-0,9900
|
Free Cash Flow
|
-
|
-
|
40,41
|
-
|
-
|
-
|
FCF-marge
|
-
|
-
|
41,28%
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
77,58%
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
110,24%
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
30/03/20
|
25/03/21
|
24/03/22
|
16/03/23
|
14/03/24
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Omzet
1 |
30,1
|
20,4
|
22,7
|
5,023
|
5,094
|
1,401
|
0,602
|
0,1978
|
2,457
|
3,555
|
3,05
|
2,55
|
0,075
|
0,15
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
13,63
|
10,31
|
9,824
|
-4,147
|
-6,536
|
-26,12
|
-9,951
|
-11,99
|
-8,936
|
-11,83
|
-8,9
|
-9,4
|
-11,88
|
-11,8
|
Operationele Marge
|
45,28%
|
50,53%
|
43,28%
|
-82,56%
|
-128,29%
|
-1.863,84%
|
-1.653,04%
|
-6.063,62%
|
-363,68%
|
-332,62%
|
-291,8%
|
-368,63%
|
-15.833,33%
|
-7.866,67%
|
Resultaat voor belastingen (EBT)
1 |
13,58
|
10,24
|
13,1
|
-3,428
|
-3,476
|
-25,04
|
-8,015
|
-11,16
|
-8,096
|
-10,84
|
-8,76
|
-9,28
|
-11,78
|
-11,72
|
Nettowinst (verlies)
1 |
11,48
|
7,498
|
11,71
|
-2,686
|
-1,361
|
-21,91
|
-5,755
|
-8,919
|
-5,982
|
-14,68
|
-6,57
|
-6,96
|
-8,831
|
-8,79
|
Nettomarge
|
38,12%
|
36,75%
|
51,61%
|
-53,48%
|
-26,72%
|
-1.563,02%
|
-956,11%
|
-4.508,79%
|
-243,47%
|
-412,82%
|
-215,41%
|
-272,94%
|
-11.774,67%
|
-5.860%
|
WPA
2 |
0,3800
|
0,2500
|
0,3400
|
-0,0800
|
-0,0400
|
-0,6800
|
-0,2000
|
-0,3100
|
-0,2000
|
-0,5000
|
-0,2100
|
-0,2200
|
-0,2800
|
-0,2800
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
11/11/21
|
24/03/22
|
12/05/22
|
11/08/22
|
10/11/22
|
16/03/23
|
11/05/23
|
10/08/23
|
9/11/23
|
14/03/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
40,4
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
27,3%
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
22,9%
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
160
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
|
0,11
|
0,77
|
0,67
|
1,43
|
-
|
-
|
Capex/omzet
|
52,68%
|
1,04%
|
0,68%
|
4,17%
|
-
|
-
|
Datum van publicatie
|
30/03/20
|
25/03/21
|
24/03/22
|
16/03/23
|
14/03/24
|
-
|
Laatste slotkoers
1,11
USD Gemiddelde koersdoel
2,5
USD Spread / Gemiddelde doel +125,23% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -16,54% | 34,7 mln. | | -12,91% | 19,08 mld. | | -46,21% | 2,65 mld. | | +18,15% | 1,87 mld. | | -3,12% | 1,61 mld. | | +23,78% | 1,21 mld. | | -10,69% | 1,02 mld. | | -20,89% | 905 mln. | | -18,10% | 682 mln. | | -7,14% | 716 mln. |
Medisch diagnose- & testmateriaal
|